220 related articles for article (PubMed ID: 32862757)
1. Comparison of Approaches for Determining Bioactivity Hits from High-Dimensional Profiling Data.
Nyffeler J; Haggard DE; Willis C; Setzer RW; Judson R; Paul-Friedman K; Everett LJ; Harrill JA
SLAS Discov; 2021 Feb; 26(2):292-308. PubMed ID: 32862757
[TBL] [Abstract][Full Text] [Related]
2. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns.
Rothenaigner I; Hadian K
SLAS Discov; 2021 Aug; 26(7):851-854. PubMed ID: 33882754
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling.
Nyffeler J; Willis C; Lougee R; Richard A; Paul-Friedman K; Harrill JA
Toxicol Appl Pharmacol; 2020 Jan; 389():114876. PubMed ID: 31899216
[TBL] [Abstract][Full Text] [Related]
4. The Cell Painting Assay as a Screening Tool for the Discovery of Bioactivities in New Chemical Matter.
Pahl A; Sievers S
Methods Mol Biol; 2019; 1888():115-126. PubMed ID: 30519943
[TBL] [Abstract][Full Text] [Related]
5. Application of Cell Painting for chemical hazard evaluation in support of screening-level chemical assessments.
Nyffeler J; Willis C; Harris FR; Foster MJ; Chambers B; Culbreth M; Brockway RE; Davidson-Fritz S; Dawson D; Shah I; Friedman KP; Chang D; Everett LJ; Wambaugh JF; Patlewicz G; Harrill JA
Toxicol Appl Pharmacol; 2023 Jun; 468():116513. PubMed ID: 37044265
[TBL] [Abstract][Full Text] [Related]
6. Creating a more strategic small molecule biophysical hit characterization workflow.
Fotsch C; Basu D; Case R; Chen Q; Koneru PC; Lo MC; Ngo R; Sharma P; Vaish A; Yi X; Zech SG; Hodder P
SLAS Discov; 2024 Jun; 29(4):100159. PubMed ID: 38723666
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic Profiling of Reference Chemicals across Biologically Diverse Cell Types Using the Cell Painting Assay.
Willis C; Nyffeler J; Harrill J
SLAS Discov; 2020 Aug; 25(7):755-769. PubMed ID: 32546035
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
Lee OW; Austin S; Gamma M; Cheff DM; Lee TD; Wilson KM; Johnson J; Travers J; Braisted JC; Guha R; Klumpp-Thomas C; Shen M; Hall MD
SLAS Discov; 2020 Jan; 25(1):9-20. PubMed ID: 31498718
[TBL] [Abstract][Full Text] [Related]
9. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
[TBL] [Abstract][Full Text] [Related]
10. Predicting compound activity from phenotypic profiles and chemical structures.
Moshkov N; Becker T; Yang K; Horvath P; Dancik V; Wagner BK; Clemons PA; Singh S; Carpenter AE; Caicedo JC
Nat Commun; 2023 Apr; 14(1):1967. PubMed ID: 37031208
[TBL] [Abstract][Full Text] [Related]
11. Cell Painting-based bioactivity prediction boosts high-throughput screening hit-rates and compound diversity.
Fredin Haslum J; Lardeau CH; Karlsson J; Turkki R; Leuchowius KJ; Smith K; Müllers E
Nat Commun; 2024 Apr; 15(1):3470. PubMed ID: 38658534
[TBL] [Abstract][Full Text] [Related]
12. A Data Analysis Pipeline Accounting for Artifacts in Tox21 Quantitative High-Throughput Screening Assays.
Hsieh JH; Sedykh A; Huang R; Xia M; Tice RR
J Biomol Screen; 2015 Aug; 20(7):887-97. PubMed ID: 25904095
[TBL] [Abstract][Full Text] [Related]
13. How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.
Jasial S; Hu Y; Bajorath J
J Med Chem; 2017 May; 60(9):3879-3886. PubMed ID: 28421750
[TBL] [Abstract][Full Text] [Related]
14. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
15. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.
McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA
SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646
[TBL] [Abstract][Full Text] [Related]
16. Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective.
Rainard JM; Pandarakalam GC; McElroy SP
SLAS Discov; 2018 Mar; 23(3):225-241. PubMed ID: 29460707
[TBL] [Abstract][Full Text] [Related]
17. Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection.
Chakravorty SJ; Chan J; Greenwood MN; Popa-Burke I; Remlinger KS; Pickett SD; Green DVS; Fillmore MC; Dean TW; Luengo JI; Macarrón R
SLAS Discov; 2018 Jul; 23(6):532-545. PubMed ID: 29699447
[TBL] [Abstract][Full Text] [Related]
18. Chemical and biological properties of frequent screening hits.
Che J; King FJ; Zhou B; Zhou Y
J Chem Inf Model; 2012 Apr; 52(4):913-26. PubMed ID: 22435989
[TBL] [Abstract][Full Text] [Related]
19. GPCR profiling: from hits to leads and from genotype to phenotype.
Cvijic ME; Sum CS; Alt A; Zhang L
Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
[TBL] [Abstract][Full Text] [Related]
20. Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaign.
Moberg A; Zander Balderud L; Hansson E; Boyd H
Assay Drug Dev Technol; 2014; 12(9-10):506-13. PubMed ID: 25415593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
